These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 24749401)
1. Enhanced cellular uptake and biodistribution of a synthetic cannabinoid loaded in surface-modified poly(lactic-co-glycolic acid) nanoparticles. Durán-Lobato M; Muñoz-Rubio I; Holgado MA; Alvarez-Fuentes J; Fernández-Arévalo M; Martín-Banderas L J Biomed Nanotechnol; 2014 Jun; 10(6):1068-79. PubMed ID: 24749401 [TBL] [Abstract][Full Text] [Related]
2. Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies. Martín-Banderas L; Alvarez-Fuentes J; Durán-Lobato M; Prados J; Melguizo C; Fernández-Arévalo M; Holgado MÁ Int J Nanomedicine; 2012; 7():5793-806. PubMed ID: 23209365 [TBL] [Abstract][Full Text] [Related]
3. Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles. Verma RK; Pandya S; Misra A J Biomed Nanotechnol; 2011 Feb; 7(1):118-20. PubMed ID: 21485832 [TBL] [Abstract][Full Text] [Related]
4. Development, Characterization and In Vitro Gastrointestinal Release of PLGA Nanoparticles Loaded with Full-Spectrum Cannabis Extracts. Villate A; Barreto GP; Nicolás MS; Aizpurua-Olaizola O; Olivares M; Usobiaga A AAPS PharmSciTech; 2024 May; 25(5):120. PubMed ID: 38816596 [TBL] [Abstract][Full Text] [Related]
5. The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats. Simon LC; Sabliov CM Drug Metab Rev; 2014 May; 46(2):128-41. PubMed ID: 24303927 [TBL] [Abstract][Full Text] [Related]
6. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations. Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281 [TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy. Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459 [TBL] [Abstract][Full Text] [Related]
8. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes. Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850 [TBL] [Abstract][Full Text] [Related]
9. Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium. Cetin M; Atila A; Kadioglu Y AAPS PharmSciTech; 2010 Sep; 11(3):1250-6. PubMed ID: 20697984 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin. Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815 [TBL] [Abstract][Full Text] [Related]
11. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859 [TBL] [Abstract][Full Text] [Related]
12. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations. Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288 [TBL] [Abstract][Full Text] [Related]
13. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles. Niu X; Zou W; Liu C; Zhang N; Fu C Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638 [TBL] [Abstract][Full Text] [Related]
14. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
16. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine. Grabovac V; Bernkop-Schnürch A Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025 [TBL] [Abstract][Full Text] [Related]
17. Biodistribution and toxicity of orally administered poly (lactic-co-glycolic) acid nanoparticles to F344 rats for 21 days. Navarro SM; Morgan TW; Astete CE; Stout RW; Coulon D; Mottram P; Sabliov CM Nanomedicine (Lond); 2016 Jul; 11(13):1653-69. PubMed ID: 27347781 [TBL] [Abstract][Full Text] [Related]
18. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer. Lee WK; Park JY; Yang EH; Suh H; Kim SH; Chung DS; Choi K; Yang CW; Park JS J Control Release; 2002 Dec; 84(3):115-23. PubMed ID: 12468215 [TBL] [Abstract][Full Text] [Related]
19. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations. Salama AH; Mahmoud AA; Kamel R AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410 [TBL] [Abstract][Full Text] [Related]
20. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency. Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]